Welcome to our dedicated page for Ambev SEC filings (Ticker: ABEV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ambev S.A. (ABEV) SEC filings page brings together the company’s disclosures as a foreign private issuer with securities listed on the New York Stock Exchange. Ambev files an annual report on Form 20-F, as highlighted in multiple press releases announcing the availability of its annual reports for successive years. These 20-F filings contain the company’s complete audited financial statements, and the press releases note that American Depositary Receipt holders may request hard copies free of charge.
In addition to its annual reports, Ambev regularly furnishes Form 6-K current reports. The examples provided include notices to shareholders about ordinary shareholders’ meetings, extracts of minutes from Board of Directors meetings, and detailed explanations of decisions to distribute dividends and interest on capital based on extraordinary balance sheets. Other 6-Ks disclose policies on executive remuneration and the grant of stock options and restricted shares, as well as a policy on hiring services related or not related to auditing, which sets conditions for engaging independent auditors and lists non-authorized services to preserve auditor independence.
Ambev also uses Form 6-K to report related party transactions, such as its agreement with its controlling shareholder Anheuser-Busch InBev SA/NV for the use of the BEES B2B digital platform, and to provide consolidated and individual forms under Article 11 of CVM Instruction 358/2002 that detail management and related persons’ transactions in Ambev shares and ADRs. These forms show initial and final positions, deliveries of restricted shares, purchases, and sales.
On Stock Titan, these filings can be paired with AI-powered summaries that explain the key points of lengthy documents, highlight items such as dividend approvals, interest on capital distributions, insider share movements, and policy changes, and help readers navigate Ambev’s 20-F and 6-K disclosures more efficiently.
Ambev reported an individual disclosure under Article 11 of CVM Instruction No. 358/2002 showing a single securities movement in July 2025. The company delivered 52,524 restricted common shares from treasury at a price of R$13.38 per share, producing a reported cash volume of R$702,771.12.
The filing shows the treasury (outstanding shares in treasury) fell from 169,428,968 to 169,376,444. No ADR holdings are reported. The report is signed by the company’s Chief Financial and Investor Relations Officer.
Ambev S.A. disclosed consolidated related‑party transactions covering July 1–31, 2025 under Article 11 of CVM Instruction 358/2002. The Board of Directors and Fiscal Council reported no changes: the Board holds 12,107,569 common shares and 468,040 ADRs, and the Fiscal Council holds 2,500 common shares.
Management began the period with 4,314,194 common shares and 19,790 ADRs. On day 8 management sold 98,200 shares at R$13.38 (R$1,313,916.00) and 63 shares at R$13.39 (R$843.57), leaving a final management position of 4,215,931 common shares and 19,790 ADRs. Each ADR is reported as equivalent to one share.
FAQ
What is the current stock price of Ambev (ABEV)?
What is the market cap of Ambev (ABEV)?
